159 filings
8-K
KTRA
Kintara Therapeutics Inc
9 May 24
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
5:15pm
8-K
KTRA
Kintara Therapeutics Inc
25 Apr 24
Regulation FD Disclosure
9:05am
8-K
KTRA
Kintara Therapeutics Inc
3 Apr 24
Kintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger Agreement
7:09am
8-K
KTRA
Kintara Therapeutics Inc
27 Feb 24
Other Events
6:59am
8-K
KTRA
Kintara Therapeutics Inc
26 Feb 24
Other Events
7:00am
8-K
8sgkn
22 Feb 24
Other Events
7:00am
8-K
fvbekbc
14 Feb 24
Kintara Therapeutics Announces Fiscal 2024 Second Quarter Financial Results and Provides Corporate Update
4:10pm
8-K
amiash
12 Feb 24
Kintara Therapeutics Announces Initiation of REM-001 Clinical Trial for the Treatment of Cutaneous Metastatic Breast Cancer
9:05am
8-K
urauwrp zkxelv
18 Dec 23
Other Events
4:10pm
8-K
xljl67gh9g6qutuq
15 Dec 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:15pm
8-K
xtwtiz0bp zu52
7 Dec 23
Kintara Therapeutics Announces Review of Strategic Alternatives
9:10am
8-K
xt6ji eyxy
5 Dec 23
Kintara Therapeutics Granted Extension by Nasdaq to Regain Compliance with the Stockholders’ Equity Continued Listing Requirement
9:10am
8-K
vgon6i61ij748wk83
21 Nov 23
Departure of Directors or Certain Officers
7:55am
8-K
bw7xdtcz202g3j
13 Nov 23
Kintara Therapeutics Announces Fiscal 2024 First Quarter Financial Results and Provides Corporate Update
4:15pm
8-K
ojdg4q
31 Oct 23
Kintara Therapeutics Announces Preliminary Topline Results From GBM AGILE Study
8:10am
8-K
005479wb1oy6rqp
10 Oct 23
Submission of Matters to a Vote of Security Holders
4:06pm
8-K
7uxjx0x1
26 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:09pm
8-K
nxtm0hgl
19 Sep 23
Entry into a Material Definitive Agreement
4:20pm
8-K
czi6k1o 5h
18 Sep 23
Kintara Therapeutics Announces Fiscal 2023 Year Financial Results and Provides Corporate Update
4:31pm
8-K
fhd vz460f
30 Jun 23
Amendments to Articles of Incorporation or Bylaws
5:11pm